778
Participants
Start Date
October 1, 2023
Primary Completion Date
October 1, 2026
Study Completion Date
October 1, 2026
Nafamostat mesilate
Nafamostat mesilate treatment group was dissolved with 5% glucose at the dosage of 2.0mg/kg/ day to a total of 50ml(Maximum concentration 10mg/ml)
5% glucose
Add 50ml of 5% glucose into a 50ml syringe
Tianjin Third Central Hospital
OTHER
Tianjin Medical University General Hospital
OTHER
Shanxi Provincial People's Hospital
OTHER_GOV
Shanxi Bethune Hospital
OTHER
Hohhot First Hospital
UNKNOWN
The First Bethune Hospital Jilin University
UNKNOWN
Northern Jiangsu People's Hospital
OTHER
The Affiliated Hospital of Nantong University
UNKNOWN
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
OTHER
The First Affiliated Hospital of Suzhou Medical
UNKNOWN
Anhui Provincial Hospita
UNKNOWN
Zhejiang Hospital
OTHER
Zhejiang Provincial People's Hospital
OTHER
The First Affiliated Hospital of Ningbo
UNKNOWN
The First Affiliated Hospital of Wenzhou
UNKNOWN
The Jiangxi Provincial People's Hospital
UNKNOWN
First Affiliated Hospital of Gannan Medical University
OTHER
The Second Affiliated Hospital Xi'an Jiaotong
UNKNOWN
LanZhou University
OTHER
The First Affiliated Hospital of Xinjiang
UNKNOWN
First Affiliated Hospital of Xinjiang Medical University
OTHER
Tongji Medical College of Huazhong University
UNKNOWN
The Second Hospital University of South China
OTHER
The Fourth Affiliated Hospital of China Medical
UNKNOWN
The First Affiliated Hospital of Liaoning
UNKNOWN
Genertec Liaoyou Gem Flower Hospital
UNKNOWN
The Tenth People's Hospital of Shenyang
UNKNOWN
The Sixth People's Hospital of Shenyang
OTHER
Dalian NO.3 People's Hospital
UNKNOWN
Benxi Cental Hospital
OTHER
Liaoyang City Central Hospital
UNKNOWN
Huludao central hospital
UNKNOWN
Xu Li
OTHER